Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SemaThera Inc logo — company profile

SemaThera Inc

Founded 2016 Canada Westmount, Canada 6 employees Venture round Total: $3.60M Biotechnology, Health and Wellness

General Information

Company Name SemaThera Inc
Founded Year 2016
Location Canada Westmount, Canada
Employees 6
Industries Biotechnology, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with SemaThera Inc. To contact SemaThera Inc, visit semathera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SemaThera Inc compare?

A PDF of SemaThera Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SemaThera Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SemaThera Inc

SemaThera is a biotechnology startup that originated as a spin-off from AmorChem Fund 1. Founded in 2016 and headquartered in Canada, the company's primary focus is on a cutting-edge target, semaphorin 3A (SEMA3A). SemaThera is dedicated to developing bispecific SEMA3A / VEGF inhibitors (traps) designed to address the issue of vascular leakage and inflammation in diabetic macular edema (DME). This technology specifically targets the 30% of DME patients who do not respond well to current anti-VEGF therapies. As of 26 March 2018, SemaThera received a significant $2.60M Venture Round investment led by Amorchem and Senju Pharmaceutical. The company's unique positioning and innovative approach to addressing an unmet need in the biotechnology space make it an intriguing prospect for potential investors.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.60M 2
Amorchem
Amorchem, Senju Pharmaceutical
26 Mar 2018
Seed Round $1.00M -
12 Jan 2017

SemaThera Inc Alternatives & Competitors

View All Alternatives
SemaThera Inc vs
Therini Bio, Inc.
Therini Bio, Inc. United States

A new approach to block vascular-mediated inflammation

Series A
15 employees
Biotechnology, Health Care
SemaThera Inc vs
Kodiak Sciences
Kodiak Sciences United States

We are a clinical stage biopharma company bringing new science to prevent and treat high prevalence...

Post-IPO Equity
108 employees
Biotechnology, Health Care
SemaThera Inc vs
Inflammx Therapeutics, Inc.
Inflammx Therapeutics, Inc. United States

Modulation of Inflammasome mediated Autoinflammation - in Ophthalmology, Nephropathy and Neurodegen...

Venture round
3 employees
Biotechnology, Health Care
View all alternatives

FAQ About SemaThera Inc

SemaThera is a spin-off company from AmorChem Fund 1, which focuses on a novel target, semaphorin 3A (SEMA3A). The Company is currently developing bispecific SEMA3A / VEGF inhibitors (traps) to prevent vascular leakage and damper the inflammation in diabetic macular edema (DME). The technology targe...
SemaThera Inc was founded in 2016.
SemaThera Inc is headquartered in Westmount, Canada.
SemaThera Inc operates in Biotechnology and Health and Wellness.
SemaThera Inc has approximately 6 employees.
SemaThera Inc has completed 2 funding rounds, raising a total of $3.60M. The latest funding stage is Venture round.
Top alternatives and competitors to SemaThera Inc include Therini Bio, Inc., Kodiak Sciences, Inflammx Therapeutics, Inc., ImmunoMet Therapeutics, Inc., Immune Pharmaceuticals Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SemaThera Inc and Therini Bio, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SemaThera Inc, https://bouncewatch.com/company/semathera, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes